
Epiclos 0.25ml Injection
Marketer
Quepreon Biologicals Pvt Ltd
Salt Composition
n-Butyl-2-cyanoacrylate (0.25ml)
Overview Epiclos 0.25ml Injection
Hemostatic injection, Epiclos 0.25ml, effectively manages bleeding by acting as a tissue sealant. Administration requires the guidance of a medical professional. Prior to use, disclose any allergies to this medicine. All current medications should be reported to your physician. Pregnant or breastfeeding individuals, and those with severe hepatic, cardiac, or renal impairment, should inform their doctor before use. No prevalent adverse effects have been observed.
Uses of Epiclos 0.25ml Injection
Hemorrhage
Major Benefits of Epiclos 0.25ml Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Epiclos 0.25ml Injection:
- No common side effects seen
How to use Epiclos 0.25ml Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Epiclos 0.25ml Injection works:
A single 0.25ml dose of Epiclos injectable tissue sealant rapidly solidifies upon contact with a surgical incision, creating a robust seal between wound margins. This action effectively controls hemorrhage and facilitates rapid wound closure and tissue regeneration.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Epiclos 0.25ml Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on Epiclos 0.25ml Injection use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Epiclos 0.25ml Injection use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The impact of Epiclos 0.25ml Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Epiclos 0.25ml Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Epiclos 0.25ml Injection to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Epiclos 0.25ml Injection :
Omit a dose of Epiclos 0.25ml Injection? Seek medical advice.
Facts to Know About Epiclos 0.25ml Injection
| Label | Value |
|---|---|
| Chemical Category | Modified Cyanoacrylate |
| Developing Habits | No. |
| Treatment Category | ALTERNATIVES |
| Action Class | Blood clotting agent |
